Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12619000025134
Ethics application status
Approved
Date submitted
13/12/2018
Date registered
10/01/2019
Date last updated
10/01/2019
Date data sharing statement initially provided
10/01/2019
Type of registration
Prospectively registered
Titles & IDs
Public title
Patient risks associated with blue and green ambient light in modern interventional suites - an anaesthetic perspective.
Query!
Scientific title
Patient risks associated with blue and green ambient light in modern interventional suites and incorrect drug identification by anaesthetic staff
Query!
Secondary ID [1]
296875
0
Nil known.
Query!
Universal Trial Number (UTN)
U1111-1225-5104
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Impaired visual performance
310801
0
Query!
Condition category
Condition code
Eye
309476
309476
0
0
Query!
Normal eye development and function
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Volunteer participants that have met the inclusion criterion of passing the Stage 1 visual tests: the Ishihara test for colour blindness, the Farnsworth D-15 hue visual test and the drug labelling test in white light conditions will progress to Stage Two and complete the Farnsworth D-15 hue and drug labelling tests using a random order of items in 1) ambient green light; and in 2) ambient blue light.
The ‘Farnsworth-Test’, 15 cups with different hues will be given to participants to be put in order of hue from the starter cup with a standard colour. Complete passing to mild failure (13-15 correctly) is deemed acceptable. Anything that results in >2 mismatched cups is considered a failure of the test. Accuracy and time to complete the test is recorded.
The Drug-Labelling-Test’, 15 names of commonly-used drugs in anaesthesia (on international standardized colour labels) will be provided on an A4 form (left side), which needs to be matched by participants using identical drug labels on the form’s right side . Accuracy and time to complete the test is recorded. The number of inaccurate selections of drug label will be recorded out of 15.
Ambient Blue light is defined as 1000+/-50 lux of blue light (~470nm) incident on the test objects. Ambient Green light is defined as 1000+/-50 lux of green light (~550nm) incident on the test objects.
The testing procedure commences immediately upon entering the room, and the total time in each light exposure is approximately 5 minutes. The researcher will administer the tests. Participants are allowed up to a maximum of 5 minutes to complete each test. All participants will experience green and blue light conditions with approximately 3 minutes between conditions, to allow for task components to be reset for the subsequent test.
Query!
Intervention code [1]
313152
0
Other interventions
Query!
Comparator / control treatment
Scores obtained under standard white light (all successes) will be compared with scores obtained under coloured light scores to assess variations in performance.
The human visual system is sensitive to different wavelengths of light; as such it will be necessary to control the illumination of each coloured ambient condition (i.e. white, blue, green). The visual standard sensitivity function for photopic vision will be used to ensure the same perceived brightness for each light source will be used when carrying out experiments.
Ambient white light is defined as 1000+/-50 lux of white light incident on the test objects.
All participants will experience the white light condition. Each participant will experience each of the light conditions, white, green and blue, sequentially, according to a randomised sequence. The 'washout' duration is approximately 3 minutes between lighting conditions.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
308434
0
Ishihara colour perception test score.
Query!
Assessment method [1]
308434
0
Query!
Timepoint [1]
308434
0
Complete test in 5 minutes.
Query!
Primary outcome [2]
308435
0
Farnsworth D-15 test score.
Query!
Assessment method [2]
308435
0
Query!
Timepoint [2]
308435
0
Complete test in 5 minutes.
Query!
Primary outcome [3]
308436
0
Drug Labelling Test score.
Query!
Assessment method [3]
308436
0
Query!
Timepoint [3]
308436
0
Complete test in 5 minutes.
Query!
Secondary outcome [1]
354952
0
Nil.
Query!
Assessment method [1]
354952
0
Query!
Timepoint [1]
354952
0
N/A
Query!
Eligibility
Key inclusion criteria
- Volunteers aged >18 years
- Anaesthetists, anaesthetic health practitioners and nurses who participate in any of prescription, preparation, administration, and checking of medications.
- Written informed consent by the volunteer.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
- A failure of the Ishihara Test.
- A failure of the Farnsworth D-15 hue test and/or drug labelling test in white light conditions.
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Sealed opaque envelopes.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software (i.e. computerised sequence generation).
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Crossover
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
The sample size and methods for this study have been devised in consultation with a statistician from QIMR Berghofer Medical Research Institute. The primary outcome is success, defined as a score of 13 or more on the Farnsworth D-15 hue test. The acceptable success rate is defined as 0.99 (acceptable failure rate < 0.01), since it would be severely detrimental to patients if anaesthetic staff were unable to distinguish between colours in theatre lighting conditions. Using a binomial test, to have 95% confidence that the success rate was greater than 0.99, we would need to observe 299 successes out of 299 anaesthetic staff recruited. Thus 300 participants involved in Stage 2 will be required to allow for balanced numbers for each randomised sequence. Summary statistics and 95% confidence intervals will be reported.
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
14/01/2019
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
16/09/2019
Query!
Actual
Query!
Date of last data collection
Anticipated
16/09/2019
Query!
Actual
Query!
Sample size
Target
300
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Recruitment hospital [1]
12720
0
Royal Brisbane & Womens Hospital - Herston
Query!
Recruitment postcode(s) [1]
25146
0
4029 - Herston
Query!
Recruitment postcode(s) [2]
25147
0
4029 - Royal Brisbane Hospital
Query!
Funding & Sponsors
Funding source category [1]
301444
0
Hospital
Query!
Name [1]
301444
0
Department of Anaesthesia, Royal Brisbane and Womens Hospital.
Query!
Address [1]
301444
0
Butterfield Street, Herston, Queensland, 4029. Australia.
Query!
Country [1]
301444
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Royal Brisbane and Women's Hospital.
Query!
Address
Butterfield Street, Herston, Queensland, 4029. Australia.
Query!
Country
Australia
Query!
Secondary sponsor category [1]
301133
0
None
Query!
Name [1]
301133
0
Query!
Address [1]
301133
0
Query!
Country [1]
301133
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
302179
0
Royal Brisbane & Womens Hospital HREC
Query!
Ethics committee address [1]
302179
0
Post Office Royal Brisbane & Women's Hospital Herston Qld 4029
Query!
Ethics committee country [1]
302179
0
Australia
Query!
Date submitted for ethics approval [1]
302179
0
Query!
Approval date [1]
302179
0
10/12/2018
Query!
Ethics approval number [1]
302179
0
LNR/2018/QRBW/43509
Query!
Summary
Brief summary
As hospitals move towards modern interventional suites, this study aims to identify potential safety risks related to ambient light-related performance deficiencies. Specifically, the aims are to measure the influence of spectral selection in the operating theatre and interventional suite environments and to interpret safety risks for patients in relation to the performance of anaesthetic staff in blue and green ambient light conditions.
Blue and green spectral conditions will negatively affect the ability of anaesthetic staff to correctly detect colour hues using the Farnsworth test and diminish performance in a drug labelling matching task, in staff who performed adequately in white light conditions. This may indicate the potential hazards of incorrect drug identification, impaired patient monitoring performance and delayed clinical response in clinical practice.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
89386
0
Prof Andre van Zundert
Query!
Address
89386
0
Royal Brisbane & Women's Hospital,
Butterfield Street, Herston. Qld. 4029.
Query!
Country
89386
0
Australia
Query!
Phone
89386
0
+617 36465673
Query!
Fax
89386
0
Query!
Email
89386
0
[email protected]
Query!
Contact person for public queries
Name
89387
0
Prof Andre van Zundert
Query!
Address
89387
0
Royal Brisbane & Women's Hospital,
Butterfield Street, Herston. Qld. 4029.
Query!
Country
89387
0
Australia
Query!
Phone
89387
0
+617 36465673
Query!
Fax
89387
0
Query!
Email
89387
0
[email protected]
Query!
Contact person for scientific queries
Name
89388
0
Prof Andre van Zundert
Query!
Address
89388
0
Royal Brisbane & Women's Hospital,
Butterfield Street, Herston. Qld. 4029.
Query!
Country
89388
0
Australia
Query!
Phone
89388
0
+617 36465673
Query!
Fax
89388
0
Query!
Email
89388
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
777
Informed consent form
376582-(Uploaded-13-12-2018-17-36-03)-Study-related document.doc
778
Study protocol
376582-(Uploaded-13-12-2018-17-37-18)-Study-related document.docx
779
Ethical approval
376582-(Uploaded-13-12-2018-17-38-16)-Study-related document.pdf
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF